Nine for 2021: The COVID-19 legacy
pharmaphorum
JANUARY 5, 2021
For example, UCB-Medisafe’s epilepsy portfolio digital companion will support patient engagement, and another US innovation, FDA approved platform including biosensor wearables and AI analytics powers Biofourmis’ Hospital@Home platform which has been rolled out nationally to help facilitate CMS’ “Acute Hospital Care at Home” program.
104 
Let's personalize your content